The Health Ministry has tightened rules for high-alcohol oral medicines sold in larger packs, requiring prescriptions, licences and stricter pharmacy records.
Can medicines containing high levels of alcohol become a source of misuse when they are freely available over the counter?
India’s Health Ministry has moved to address that concern by tightening the sale and licensing rules for certain oral medicinal formulations containing ethyl alcohol.
Under the amended Drugs Rules, 1945,formulations containing containing over 12% ethyl alcohol and sold in bottles larger than 30 mL will no longer receive the earlier exemption under Schedule K.
These products must now obtain the required licences and can be dispensed only against a prescription from a registered medical practitioner. They have also been brought under Schedule H1, which requires stricter pharmacy record-keeping. ()
Advertisement
High-Alcohol Medicines in Larger Packs Now Need Prescription
The new restriction applies when a medicinal formulation meets both conditions:
- It contains more than 12% v/v ethyl alcohol
- It is sold in a quantity exceeding 30 mL.
Such products can no longer be purchased directly over the counter without medical authorisation. Pharmacies must dispense them only against a valid prescription from a registered medical practitioner.
The amendment is intended to ensure that high-alcohol medicinal formulations remain within the regulated pharmaceutical supply chain rather than being easily purchased for non-medical use.
Advertisement
Schedule H1 Brings Stricter Sale Controls
The affected formulations have been shifted to Schedule H1 of the Drugs Rules, 1945.
Schedule H1 requires tighter controls over how medicines are prescribed, dispensed and recorded. Pharmacies must maintain details of sales involving these products, increasing accountability and making it easier for regulators to identify possible misuse or diversion.
Manufacturers and sellers must also obtain the necessary licences under the Drugs and Cosmetics Act, 1940.
Advertisement
High-Alcohol Tinctures Raised Concerns Over Misuse
Certain products, including tinctures of cardamom, ginger and other aromatic preparations, had historically been exempted from licensing requirements under Schedule K.
The Health Ministry said some of these formulations contained alcohol concentrations as high as 80% to 90% v/v.
Such high levels made the products vulnerable to misuse for intoxication, leading several state governments to request stronger regulation.
New Rules Target Misuse Without Blocking Treatment
The amendment does not ban alcohol-containing medicines. It specifically removes the exemption for formulations containing more than 12% ethyl alcohol when supplied in quantities greater than 30 mL.
Patients who genuinely require these medicines can continue to obtain them with a valid medical prescription.()
The goal is to preserve legitimate therapeutic access while reducing opportunities for abuse, self-medication and diversion.
Smaller Packs and Lower-Alcohol Formulations Are Not Targeted
Medicines containing 12% or less ethyl alcohol are not covered by this particular restriction. Similarly, the amended Schedule K provision concerns high-alcohol formulations supplied in quantities exceeding 30 mL.
The rule therefore focuses on products considered to have a greater potential for misuse rather than imposing a blanket restriction on every medicine that contains alcohol.
Homeopathic Medicines Already Face Similar Limits
Homeopathic medicines containing alcohol have been subject to a comparable limit since 1994.
An exception allows supplies to hospitals and dispensaries in bottles of up to 100 mL.
The latest amendment extends stronger control to other high-alcohol medicinal formulations that had remained exempt under Schedule K.
Why Alcohol-Containing Medicines Can Be Misused
Ethyl alcohol may be used in medicines as a solvent, preservative or ingredient that helps dissolve active compounds. However, ethanol is also a psychoactive substance with dependence-producing properties.
Excessive alcohol exposure can affect judgment, coordination and behaviour and may contribute to injuries, dependence and long-term damage to the liver, heart, brain and other organs.
When a medicinal preparation contains a very high alcohol concentration and is sold in a larger volume, it may be consumed for intoxication rather than for its intended medical purpose.
Pharmacies Must Strengthen Dispensing Records
Pharmacists will now have a greater responsibility when selling the affected formulations. They must verify that the medicine has been prescribed by a registered medical practitioner and maintain the records required for Schedule H1 medicines.
This approach creates traceability across the supply chain and may help regulators detect unusual purchasing patterns.
Consumers who previously bought certain formulations without medical consultation may now need to obtain a prescription.
Rules May Reduce Self-Medication and Diversion
Easy access to high-alcohol medicines can encourage self-medication or repeated non-medical use. It may also allow products intended for therapeutic purposes to be diverted and consumed as intoxicants.
Prescription controls help ensure that the medicine is selected for an appropriate clinical reason, used at the correct dose and reviewed for possible interactions or safety concerns.
The rule also reinforces that medicinal products should not be considered automatically safe simply because they were previously available without a prescription.
India Strengthens Oversight of Alcohol-Based Medicines
The amendment strengthens control over the manufacture, distribution and sale of high-alcohol medicinal formulations. Removing the Schedule K exemption means affected products must meet formal licensing requirements.
Moving them into Schedule H1 adds medical supervision and stricter documentation at the pharmacy level. The Health Ministry expects the change to reduce diversion and misuse while preserving access for patients who need these medicines for legitimate treatment.
Prescription Rule Balances Access with Public Safety
The new regulation is designed as a safeguard rather than a complete ban. Patients can still receive the affected medicines, but their use will now involve medical advice and greater pharmacy accountability.
For consumers, the key message is clear: oral medicines containing high concentrations of alcohol in larger bottles should be used only for legitimate medical purposes and under professional supervision.
For regulators, the change closes an exemption that had allowed some highly alcoholic products to remain too easily accessible.
References:
- Government amends Drugs Rules, 1945 to Strengthen Regulation of High Alcohol-Containing Drug Formulations- (https://www.pib.gov.in/PressReleasePage.aspx?PRID=2283196®=48&lang=2)
Source-Medindia